Publications

C-type lectin receptor CLEC4A2 promotes tissue adaptation of macrophages and protects against atherosclerosis

Park I. et al, (2022), Nature Communications, 13

Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture-prone atherosclerotic plaques.

Edsfeldt A. et al, (2022), Eur Heart J, 43, 1864 - 1877

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58

CD200 Limits Monopoiesis and Monocyte Recruitment in Atherosclerosis.

Kassiteridi C. et al, (2021), Circ Res, 129, 280 - 295

Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas.

Zernecke A. et al, (2020), Circ Res, 127, 402 - 426

Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity.

Cole JE. et al, (2018), Cardiovasc Res, 114, 1360 - 1371

Functional diversity of macrophages in vascular biology and disease.

Park I. et al, (2017), Vascul Pharmacol, 99, 13 - 22

Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.

Seneviratne AN. et al, (2017), Circulation, 136, 1140 - 1154

Corrigendum to "Low shear stress induces M1 macrophage polarization in murine thin-cap atherosclerotic plaques" [J Mol Cell Cardiol, 89B (2015) 168-172]

Seneviratne AN. et al, (2016), Journal of Molecular and Cellular Cardiology, 91

Low shear stress induces M1 macrophage polarization in murine thin-cap atherosclerotic plaques.

Seneviratne AN. et al, (2015), J Mol Cell Cardiol, 89, 168 - 172

Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.

Cole JE. et al, (2015), Proc Natl Acad Sci U S A, 112, 13033 - 13038

B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10.

Strom AC. et al, (2015), Thromb Haemost, 114, 835 - 847

Oxovanadium-based inhibitors can drive redox-sensitive cytotoxicity in neuroblastoma cells and synergise strongly with buthionine sulfoximine

Clark O. et al, (2015), Cancer Letters, 357, 316 - 327

Cookies on this website